CUE BIOPHARMA INC (CUE): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in CUE. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
3
13F filers
Aggregate Value
$4.0M
Across holders
Last Price
$4.76
2026-11-18
Sector
—
GICS
Quarterly fund activity2 increased1 reduced0 exited
Institutional Holders of CUE
↗
3 holders
Manager⇅Type⇅Shares⇅Market Value▼% of Total⇅% of Portfolio⇅Action⇅QoQ Change⇅Quarter⇅
Tetragon Partners GP Ltd
CIK 0001515070
Hedge Fund94K$3.0M73.4%0.5%Added—Q2 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund26K$809K20.0%0.0%Added—Q2 2026
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
Hedge Fund10K$266K6.6%0.0%Reduced$-114KQ3 2026
Recent insider activity
Form 4 purchases and sales · 22 Aug 2026 – 19 Nov 2026
0 buyers · $03 sellers · $389K4 transactions
Insider ⇅Trades ⇅Bought ⇅Sold ⇅Largest ⇅Latest ▼
Lin Shao-Lee
Chief Executive Officer
2
0 buy · 2 sell
—$305K$275K12 Oct 2026SEC ↗
Meluzio Michael Vincent
VP, Prin. Accounting Officer
1
0 buy · 1 sell
—$32K$32K12 Oct 2026SEC ↗
Ray Sumita
Chief Legal Compliance Officer
1
0 buy · 1 sell
—$52K$52K12 Oct 2026SEC ↗
Chief Executive Officer
2 tradesNo buys$305K sold
Largest $275K · latest 12 Oct 2026SEC ↗
VP, Prin. Accounting Officer
1 tradesNo buys$32K sold
Largest $32K · latest 12 Oct 2026SEC ↗
Chief Legal Compliance Officer
1 tradesNo buys$52K sold
Largest $52K · latest 12 Oct 2026SEC ↗
Distinct buyers and sellers may overlap. “Largest” is the largest reported transaction value in this window. Expand a row to see up to five recent filings.